Search Results

There are 9891 results for: content related to: Topical and oral bexarotene

  1. Retinoids

    Standard Article

    Burger's Medicinal Chemistry and Drug Discovery

    Marcia I. Dawson

    Published Online : 15 SEP 2010, DOI: 10.1002/0471266949.bmc065.pub2

  2. U.K. consensus statement on safe clinical prescribing of bexarotene for patients with cutaneous T-cell lymphoma

    British Journal of Dermatology

    Volume 168, Issue 1, January 2013, Pages: 192–200, J.J. Scarisbrick, S. Morris, R. Azurdia, T. Illidge, E. Parry, R. Graham-Brown, R. Cowan, E. Gallop-Evans, R. Wachsmuth, M. Eagle, A.S. Wierzbicki, H. Soran, S. Whittaker and E.M. Wain

    Article first published online : 3 DEC 2012, DOI: 10.1111/bjd.12042

  3. A selective retinoid X receptor agonist bexarotene (LGD1069, Targretin) prevents and overcomes multidrug resistance in advanced prostate cancer

    The Prostate

    Volume 66, Issue 3, 15 February 2006, Pages: 305–316, Wan-Ching Yen and William W. Lamph

    Article first published online : 21 OCT 2005, DOI: 10.1002/pros.20347

  4. Bexarotene therapy for mycosis fungoides and Sézary syndrome

    British Journal of Dermatology

    Volume 160, Issue 6, June 2009, Pages: 1299–1307, R.A. Abbott, S.J. Whittaker, S.L. Morris, R. Russell-Jones, T. Hung, S.J. Bashir and J.J. Scarisbrick

    Article first published online : 16 FEB 2009, DOI: 10.1111/j.1365-2133.2009.09037.x

  5. The optimal use of bexarotene in cutaneous T-cell lymphoma

    British Journal of Dermatology

    Volume 157, Issue 3, September 2007, Pages: 433–440, R. Gniadecki, C. Assaf, M. Bagot, R. Dummer, M. Duvic, R. Knobler, A. Ranki, P. Schwandt and S. Whittaker

    Article first published online : 6 JUN 2007, DOI: 10.1111/j.1365-2133.2007.07975.x

  6. Minimizing adverse side-effects of oral bexarotene in cutaneous T-cell lymphoma: an expert opinion

    British Journal of Dermatology

    Volume 155, Issue 2, August 2006, Pages: 261–266, C. Assaf, M. Bagot, R. Dummer, M. Duvic, R. Gniadecki, R. Knobler, A. Ranki, P. Schwandt and S. Whittaker

    Article first published online : 12 MAY 2006, DOI: 10.1111/j.1365-2133.2006.07329.x

  7. Bexarotene activates the p53/p73 pathway in human cutaneous T-cell lymphoma

    British Journal of Dermatology

    Volume 160, Issue 3, March 2009, Pages: 519–526, N. Nieto-Rementería, G. Pérez-Yarza, M.D. Boyano, A. Apraiz, R. Izu, J.L. Díaz-Pérez and A. Asumendi

    Article first published online : 25 NOV 2008, DOI: 10.1111/j.1365-2133.2008.08931.x

  8. You have free access to this content
    Absence of modulation of CD4+CD25high regulatory T cells in CTCL patients treated with bexarotene

    Experimental Dermatology

    Volume 19, Issue 8, August 2010, Pages: e95–e102, Anne Chantal Knol, Gaëlle Quéreux, Anabelle Brocard, Fabienne Ballanger, Amir Khammari, Jean-Michel Nguyen and Brigitte Dréno

    Article first published online : 21 OCT 2009, DOI: 10.1111/j.1600-0625.2009.00993.x

  9. Modulation by bexarotene of mRNA expression of genes in mouse lung tumors

    Molecular Carcinogenesis

    Volume 47, Issue 3, March 2008, Pages: 165–171, Fadel S. Alyaqoub, Yue Liu, Lianhui Tao, Vernon E. Steele, Ronald A. Lubet and Michael A. Pereira

    Article first published online : 11 SEP 2007, DOI: 10.1002/mc.20383

  10. Oral retinoids and plasma lipids

    Dermatologic Therapy

    Volume 26, Issue 5, September/October 2013, Pages: 404–410, Jessica S. Lilley, MacRae F. Linton and Sergio Fazio

    Article first published online : 4 OCT 2013, DOI: 10.1111/dth.12085

  11. Lack of apoptosis of Sézary cells in the circulation following oral bexarotene therapy

    British Journal of Dermatology

    Volume 152, Issue 6, June 2005, Pages: 1199–1205, S. Brennand, V.R. Sutton, J. Biagi, J.A. Trapani, D. Westerman, C.J. McCormack, J.F. Seymour, G. Kennedy and H.M. Prince

    Article first published online : 22 JUN 2005, DOI: 10.1111/j.1365-2133.2005.06539.x

  12. Novel treatment of chronic severe hand dermatitis with bexarotene gel

    British Journal of Dermatology

    Volume 150, Issue 3, March 2004, Pages: 545–553, J.M. Hanifin, V. Stevens, P. Sheth and D. Breneman

    Article first published online : 19 MAR 2004, DOI: 10.1046/j.1365-2133.2003.05729.x

  13. You have full text access to this OnlineOpen article
    Bexarotene blunts malignant T-cell chemotaxis in Sezary syndrome: Reduction of chemokine receptor 4-positive lymphocytes and decreased chemotaxis to thymus and activation-regulated chemokine

    American Journal of Hematology

    Volume 82, Issue 9, September 2007, Pages: 792–797, Stephen K. Richardson, Sarah B. Newton, Tami L. Bach, Jeanne B. Budgin, Bernice M. Benoit, Julie H. Lin, Jessica S. Yoon, Maria Wysocka, Charles S. Abrams and Alain H. Rook

    Article first published online : 1 JUN 2007, DOI: 10.1002/ajh.20952

  14. Retinoids and Rexinoids in Lung Cancer Prevention and Treatment

    Lung Cancer, Third Edition

    Nishin A. Bhadkamkar, Fadlo R. Khuri, Pages: 386–399, 2008

    Published Online : 16 APR 2008, DOI: 10.1002/9780470696330.ch24

  15. You have free access to this content
    Efficacy and safety of bexarotene combined with psoralen–ultraviolet A (PUVA) compared with PUVA treatment alone in stage IB–IIA mycosis fungoides: final results from the EORTC Cutaneous Lymphoma Task Force phase III randomized clinical trial 21011 (NCT00056056)

    British Journal of Dermatology

    Volume 167, Issue 3, September 2012, Pages: 678–687, S. Whittaker, P. Ortiz, R. Dummer, A. Ranki, B. Hasan, B. Meulemans, S. Gellrich, R. Knobler, R. Stadler and M. Karrasch

    Article first published online : 27 AUG 2012, DOI: 10.1111/j.1365-2133.2012.11156.x

  16. Interventions for mycosis fungoides

    Intervention Review

    The Cochrane Library

    Tobias Weberschock, Reinhard Strametz, Maria Lorenz, Christoph Röllig, Charles Bunch, Andrea Bauer and Jochen Schmitt

    Published Online : 12 SEP 2012, DOI: 10.1002/14651858.CD008946.pub2

  17. Treatment of cutaneous T-cell lymphoma with retinoids

    Dermatologic Therapy

    Volume 19, Issue 5, September 2006, Pages: 264–271, Chunlei Zhang and Madeleine Duvic

    Article first published online : 2 OCT 2006, DOI: 10.1111/j.1529-8019.2006.00083.x

  18. New Advances in the Management of Cutaneous T-Cell Lymphoma

    Cancer Practice

    Volume 9, Issue 1, January/February 2001, Pages: 52–54, Sallie K. Young

    Article first published online : 28 JUN 2008, DOI: 10.1111/j.1523-5394.2001.91010.pp.x

  19. You have full text access to this OnlineOpen article
    Results of a Phase II trial of oral bexarotene (Targretin) combined with interferon alfa-2b (Intron-A) for patients with cutaneous T-cell lymphoma

    Cancer

    Volume 109, Issue 9, 1 May 2007, Pages: 1799–1803, David J. Straus, Madeleine Duvic, Timothy Kuzel, Steven Horwitz, Marie-France Demierre, Patricia Myskowski and Steven Steckel

    Article first published online : 15 MAR 2007, DOI: 10.1002/cncr.22596

  20. A multiparameter flow cytometric analysis of the effect of bexarotene on the epidermis of the psoriatic lesion

    British Journal of Dermatology

    Volume 149, Issue 3, September 2003, Pages: 506–512, M.E.J. Franssen, J.V. Smit, P.E.J. Van Erp and P.C.M. Van de Kerkhof

    Article first published online : 23 SEP 2003, DOI: 10.1046/j.1365-2133.2003.05474.x